TREX WIND-DOWN, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 89 rows, 89 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2023-04-15: Reporting owner Koconis John; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2023-04-15: Reporting owner Gaal Lubor; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2023-04-15: Reporting owner Mendelsohn Alan; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2023-04-15: Reporting owner Pirozzi Gianluca; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-04-15 | Koconis John Officer (CEO & Chairman) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +45,010 45,010 owned after | $1.66 exercise price | 2023-04-18 | |
| 2023-04-15 | Gaal Lubor Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,100 4,100 owned after | $1.66 exercise price | 2023-04-18 | |
| 2023-04-15 | Mendelsohn Alan Officer (EVP & CMO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,505 22,505 owned after | $1.66 exercise price | 2023-04-18 | |
| 2023-04-15 | Pirozzi Gianluca Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,100 4,100 owned after | $1.66 exercise price | 2023-04-18 | |
| 2023-04-15 | Sitar Edward J Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,327 5,327 owned after | $1.66 exercise price | 2023-04-18 | |
| 2023-04-15 | Cohen David E Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,100 4,100 owned after | $1.66 exercise price | 2023-04-18 | |
| 2023-04-15 | Lucchese Joseph Officer (EVP & CFO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,505 22,505 owned after | $1.66 exercise price | 2023-04-18 | |
| 2022-04-15 | Lucchese Joseph Officer (CFO,EVP,Secretary&Treasurer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $0.31 exercise price | 2022-04-19 | |
| 2022-04-15 | Mendelsohn Alan Officer (Chief Medical Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $0.31 exercise price | 2022-04-19 | |
| 2022-04-15 | Koconis John Director, Officer (CEO & Chairman of the Board) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +600,000 600,000 owned after | $0.31 exercise price | 2022-04-19 | |
| 2022-04-15 | Cohen David E Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $0.31 exercise price | 2022-04-19 | |
| 2022-04-15 | Sitar Edward J Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $0.31 exercise price | 2022-04-19 | |
| 2022-04-15 | Pirozzi Gianluca Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $0.31 exercise price | 2022-04-19 | |
| 2022-04-15 | Gaal Lubor Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $0.31 exercise price | 2022-04-19 | |
| 2021-09-27 | Lucchese Joseph Officer (CFO, Executive VP & Treasurer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +361,163 361,163 owned after | $0.92 exercise price | 2021-09-29 | |
| 2021-09-14 | Rome Zachary Director, Officer (COO, Executive VP & Secretary) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +561,000 561,000 owned after | $0.89 exercise price | 2021-09-16 | |
| 2021-09-14 | Koconis John Director, Officer (CEO & President) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +890,000 890,000 owned after | $0.89 exercise price | 2021-09-16 | |
| 2021-07-01 | Sitar Edward J Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +47,623 47,623 owned after | $1.18 exercise price | 2021-07-06 | |
| 2021-07-01 | Pirozzi Gianluca Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +47,623 47,623 owned after | $1.18 exercise price | 2021-07-06 | |
| 2021-07-01 | Mendelsohn Alan Officer (Chief Medical Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +347,991 347,991 owned after | $1.18 exercise price | 2021-07-06 | |
| 2021-07-01 | Gaal Lubor Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +71,893 71,893 owned after | $1.18 exercise price | 2021-07-06 | |
| 2021-07-01 | Cohen David E Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +71,893 71,893 owned after | $1.18 exercise price | 2021-07-06 | |
| 2020-06-08 | BROENNIMAN LINDA A Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,270 24,270 owned after | $2.87 exercise price | 2020-06-09 | |
| 2020-06-08 | Stocum Michael Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,270 24,270 owned after | $2.87 exercise price | 2020-06-09 | |
| 2020-06-08 | Lucchese Joseph Officer (Executive VP & CFO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +97,083 97,083 owned after | $2.87 exercise price | 2020-06-09 | |
| 2020-06-08 | Sitar Edward J Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,270 24,270 owned after | $2.87 exercise price | 2020-06-09 | |
| 2020-06-08 | Pirozzi Gianluca Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,270 24,270 owned after | $2.87 exercise price | 2020-06-09 | |
| 2020-06-08 | Bragg Kimberly Officer (Controller) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +38,833 38,833 owned after | $2.87 exercise price | 2020-06-09 | |
| 2019-07-16 | Bosacki Steven Officer (Chief Operating Officer) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +91,000 91,000 owned after | $0.44 | 2019-07-18 | |
| 2019-06-12 | Goto Joyce Other (Chief Accounting Officer) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +70,000 70,000 owned after | $0.84 | 2019-06-14 | |
| 2019-06-12 | Chan Kin Foong Officer (EVP of R&D) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +77,100 77,100 owned after | $0.84 | 2019-06-14 | |
| 2019-06-12 | Tierney David S Officer (Pres and CEO) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +360,000 360,000 owned after | $0.84 | 2019-06-14 | |
| 2019-06-12 | Plott Ronald Todd Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +32,700 32,700 owned after | $0.84 | 2019-06-14 | |
| 2019-06-12 | Morlock Stephen Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +32,700 32,700 owned after | $0.84 | 2019-06-14 | |
| 2019-06-12 | Hubbard Michael Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +32,700 32,700 owned after | $0.84 | 2019-06-14 | |
| 2019-02-01 | Plott Ronald Todd Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +133,000 133,000 owned after | $0.11 | 2019-02-21 | |
| 2019-02-01 | Plott Ronald Todd Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 333,000 owned after | $0.11 | 2019-02-21 | |
| 2019-02-01 | Plott Ronald Todd Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +34,000 367,000 owned after | $0.20 | 2019-02-21 | |
| 2019-02-01 | Plott Ronald Todd Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +51,000 418,000 owned after | $0.20 | 2019-02-21 | |
| 2018-10-30 | Goto Joyce Other (Chief Accounting Officer) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +470,000 470,000 owned after | $0.17 | 2018-10-31 | |
| 2018-10-30 | Goto Joyce Other (Chief Accounting Officer) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +77,000 77,000 owned after | $0.20 | 2018-10-31 | |
| 2018-10-12 holding as of filing | Goto Joyce Other (Chief Accounting Officer) | 3 | Option to purchase common stock Derivative · Direct | Holding | $1.67 exercise price | 2018-10-12 | ||
| 2018-10-12 holding as of filing | Goto Joyce Other (Chief Accounting Officer) | 3 | Option to purchase common stock Derivative · Direct | Holding | $0.65 exercise price | 2018-10-12 | ||
| 2018-10-12 holding as of filing | Goto Joyce Other (Chief Accounting Officer) | 3 | Option to purchase common stock Derivative · Direct | Holding | $0.62 exercise price | 2018-10-12 | ||
| 2018-10-12 holding as of filing | Goto Joyce Other (Chief Accounting Officer) | 3 | Option to purchase common stock Derivative · Direct | Holding | $0.42 exercise price | 2018-10-12 | ||
| 2018-10-12 holding as of filing | Goto Joyce Other (Chief Accounting Officer) | 3 | Option to purchase common stock Derivative · Direct | Holding | $0.74 exercise price | 2018-10-12 | ||
| 2018-10-12 holding as of filing | Goto Joyce Other (Chief Accounting Officer) | 3 | Option to purchase common stock Derivative · Direct | Holding | $0.10 exercise price | 2018-10-12 | ||
| 2018-10-12 holding as of filing | Goto Joyce Other (Chief Accounting Officer) | 3 | Option to purchase common stock Derivative · Direct | Holding | $0.20 exercise price | 2018-10-12 | ||
| 2018-09-11 | Tierney David S Director, Officer (CEO) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,400,000 7,400,000 owned after | $0.22 | 2018-09-13 | |
| 2018-09-10 | Krammer Anja B Director, Officer (President) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,042,000 1,042,000 owned after | $0.20 exercise price | 2018-09-11 | |
| 2018-01-08 | Krammer Anja B Director, Officer (President) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,960,000 1,960,000 owned after | $0.11 exercise price | 2018-01-09 | |
| 2017-12-20 | Morlock Stephen Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +450,000 450,000 owned after | $0.10 exercise price | 2017-12-22 | |
| 2017-12-20 | Morlock Stephen Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +205,000 205,000 owned after | $0.20 exercise price | 2017-12-22 | |
| 2017-12-20 | Krammer Anja B Director, Officer (President) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +940,000 940,000 owned after | $0.10 exercise price | 2017-12-22 | |
| 2017-12-20 | Kitchener Gregory David Officer (Chief Financial Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +900,000 900,000 owned after | $0.10 exercise price | 2017-12-22 | |
| 2017-12-20 | Kitchener Gregory David Officer (Chief Financial Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +414,000 414,000 owned after | $0.20 exercise price | 2017-12-22 | |
| 2017-12-20 | Hubbard Michael Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +450,000 450,000 owned after | $0.10 exercise price | 2017-12-22 | |
| 2017-12-20 | Hubbard Michael Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +205,000 205,000 owned after | $0.20 exercise price | 2017-12-22 | |
| 2017-12-20 | Chan Kin Foong Officer (EVP of R&D) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +900,000 900,000 owned after | $0.10 exercise price | 2017-12-22 | |
| 2017-12-20 | Chan Kin Foong Officer (EVP of R&D) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +414,000 414,000 owned after | $0.20 exercise price | 2017-12-22 | |
| 2017-04-18 | Chan Kin Foong Officer (EVP of R&D) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +435,000 435,000 owned after | $0.74 | 2017-04-19 | |
| 2017-04-18 | Kitchener Gregory David Officer (Chief Financial Officer) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +290,000 290,000 owned after | $0.74 | 2017-04-19 | |
| 2017-04-18 | Krammer Anja B Officer (President) | 4 | Option of purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,060,000 1,060,000 owned after | $0.74 | 2017-04-19 | |
| 2017-04-18 | VONTZ CHARLES GREGORY Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $0.74 | 2017-04-19 | |
| 2017-04-18 | Morlock Stephen Director | 4 | Option to purchase common stock Derivative · Indirect · By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $0.74 | 2017-04-19 | |
| 2017-04-18 | Hubbard Michael Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $0.74 | 2017-04-19 | |
| 2017-01-18 | VONTZ CHARLES GREGORY Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,000 65,000 owned after | $0.45 | 2017-01-20 | |
| 2017-01-18 | VONTZ CHARLES GREGORY Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $0.45 | 2017-01-20 | |
| 2016-12-08 | Chan Kin Foong Officer (EVP of R&D) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $0.42 | 2016-12-12 | |
| 2016-12-08 | Kitchener Gregory David Officer (Chief Financial Officer) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +175,000 175,000 owned after | $0.42 | 2016-12-12 | |
| 2016-12-08 | Krammer Anja B Officer (President) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +400,000 400,000 owned after | $0.42 | 2016-12-12 | |
| 2016-12-08 | Morlock Stephen Director | 4 | Option to purchase common stock Derivative · Indirect · By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $0.42 | 2016-12-12 | |
| 2016-12-08 | Hubbard Michael Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $0.42 | 2016-12-12 | |
| 2016-07-21 | Chan Kin Foong Officer (EVP of R&D) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +170,000 225,000 owned after | $0.62 | 2016-07-25 | |
| 2016-07-21 | Kitchener Gregory David Officer (Chief Financial officer) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +110,000 400,000 owned after | $0.62 | 2016-07-25 | |
| 2016-07-21 | Krammer Anja B Officer (President) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +360,000 465,000 owned after | $0.62 | 2016-07-25 | |
| 2016-07-21 | Barbarosh Craig A. Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,000 175,000 owned after | $0.62 | 2016-07-25 | |
| 2016-07-21 | Morlock Stephen Director | 4 | Option to purchase common stock Derivative · Indirect · By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,000 175,000 owned after | $0.62 | 2016-07-25 | |
| 2016-07-21 | Hubbard Michael Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,000 195,000 owned after | $0.62 | 2016-07-25 | |
| 2016-07-01 | Kitchener Gregory David Officer (Chief Financial officer) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,000 290,000 owned after | $0.65 | 2016-07-06 | |
| 2016-07-01 | Chan Kin Foong Officer (EVP of R&D) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,000 55,000 owned after | $0.65 | 2016-07-06 | |
| 2016-07-01 | Krammer Anja B Director, Officer (President) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +105,000 105,000 owned after | $0.65 | 2016-07-06 | |
| 2016-06-13 | Morlock Stephen Director | 4 | Option to purchase common stock Derivative · Indirect · By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 110,000 owned after | $0.76 | 2016-06-14 | |
| 2016-06-13 | Barbarosh Craig A. Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 110,000 owned after | $0.76 | 2016-06-14 | |
| 2016-06-13 | Hubbard Michael Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +80,000 130,000 owned after | $0.76 | 2016-06-14 | |
| 2016-01-26 | Barbarosh Craig A. Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $1.55 | 2016-01-27 | |
| 2015-08-10 | Kitchener Gregory David Officer (CFO) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +235,000 235,000 owned after | $1.67 | 2015-08-12 | |
| 2015-04-30 | Morlock Stephen Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $3.00 | 2015-05-01 | |
| 2015-04-30 | Hubbard Michael Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $3.00 | 2015-05-01 |